SFX by Ex Libris Inc.

Title:	More SNPs on the way
Source:	Science [0036-8075] Garber, K yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Niu, J. "Oxaliplatin-Induced Thrombotic Thrombocytopenic Purpura: Case Report and Literature Review." Journal of clinical oncology 30.31 (2012): 312-4.
description	2.	Marder, E. "Thrombotic Thrombocytopenic Purpura (TTP)-Like Illness Associated with Intravenous Opana ER Abuse - Tennessee, 2012." Morbidity and mortality weekly report 62.1 (2013): 1-4.
description	3.	Arnold, Theodore M. "A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia." Journal of thrombosis and haemostasis 11.1 (2012): 169-176.
description	4.	Salvetti, A. "Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study." Journal of cardiovascular pharmacology 19.5 (1992): 670-673.
description	5.	Ittmann, S. "Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women." Cancer research 66.3 (2006): 1880-1.
description	6.	Koutras, A K K. "Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis." Oncology (2004): 179-182.
description	7.	Cuker, A. "Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis." Blood 120.20 (2012): 4160-4167.
description	8.	Chen, Vivien M Y M. "An immediate hemolytic reaction induced by repeated administration of oxaliplatin." Transfusion 44.6 (2004): 838-43.
description	9.	Zhang, Y. "Immunoprotection versus immunopathology by type I and III interferon against human metapneumovirus." The journal of immunology 202.1 Supplement (2019): 198-.
description	10.	Kollmannsberger, C. "Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy." World Journal of Urology (2001): 120-125.
description	11.	Ambruzs, Josephine M. "Thrombotic Microangiopathy and Acute Kidney Injury Associated With Intravenous Abuse of an Oral Extended-Release Formulation of Oxymorphone Hydrochloride: Kidney Biopsy Findings and Report of 3 Cases." American journal of kidney diseases 63.6 (2014): 1022-1026.
description	12.	Parikh, Rahul A. "Opana-ER used the wrong way: intravenous abuse leading to microangiopathic hemolysis and a TTP-like syndrome." Blood 122.20 (2013): 3403-3403.
description	13.	Peces, R. "Haemolytic-uraemic syndrome in a heroin addict." Nephrology, Dialysis, Transplantation 13.12 (1998): 3197-3199.
description	14.	Meehan, Shane M. "Thrombotic Microangiopathy and Peritubular Capillary C4d Expression in Renal Allograft Biopsies." Clinical journal of the American Society of Nephrology (2010): 395-403.
description	15.	Kallianpur, AR R. "Mitochondrial DNA G10398A polymorphism and risk of invasive breast cancer in African American women." Journal of women's health 15.6 (2006): 675-676.
description	16.	Saif, Leslie W. "Oxaliplatin-mediated autoimmune thrombocytopenia." Clinical colorectal cancer (2009): 61-62.
description	17.	Pathania, D. "Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism." Advanced Drug Delivery Reviews 61.14 (2009): 1250-1275.
description	18.	Wang, W. "Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review." Pharmacy World & Science 31.5 (2009): 538-41.
description	19.	Bougie, R H W. "Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management." Journal of thrombosis and haemostasis 7.6 (2009): 911-918.
description	20.	Harlow, D.G. G. "A probability model for the growth of corrosion pits in aluminum alloys induced by constituent particles." Engineering fracture mechanics 59.3 (1998): 305-325.